Original Research
Published on 12 May 2020
Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
in Cancer Genetics
Frontiers in Oncology
doi 10.3389/fonc.2020.00729
- 9,447 views
- 15 citations

